Allerta Dronetplus (2016) Triptamine. [Online] Available at: http://allerta.dronetplus.eu/triptamine.html. Accessed 28 July 2023. http://allerta.dronetplus.eu/triptamine.html

Altuncı YA, Aydoğdu M, Açıkgöz E, Güven Ü, Düzağaç F, Atasoy A, Dağlıoğlu N, Annette Akgür S (2021) New psychoactive substance 5-MeO-MiPT in vivo acute toxicity and hystotoxicological study. Balkan Med J 38(1):34–42. https://doi.org/10.4274/balkanmedj.galenos.2020.2019.11.68

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araújo AM, Carvalho F, MdeL B, Guedes de Pinho P, Carvalho M (2015) The hallucinogenic world of tryptamines: an updated review. Arch Toxicol 89(8):1151–1173. https://doi.org/10.1007/s00204-015-1513-x

Article  CAS  PubMed  Google Scholar 

Arfè R, Bilel S, Tirri M, Corli G, Bergamin E, Serpelloni G, Bassi M, Borsari M, Boccuto F, Bernardi T, Caruso L, Alkilany AM, Rachid O, Botrè F, De-Giorgio F, Marti M (2023) Comprehensive evaluation of the pharmacological and toxicological effects of γ-valerolactone as compared to γ-hydroxybutyric acid: insights from in vivo and in silico models. Drug Alcohol Depend 252:110951. https://doi.org/10.1016/j.drugalcdep.2023.110951

Article  CAS  PubMed  Google Scholar 

Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacol Rev 73(1):310–520. https://doi.org/10.1124/pr.118.015552

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumeister D, Tojo LM, Tracy DK (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol 5(2):97–132. https://doi.org/10.1177/2045125314559539

Article  PubMed  PubMed Central  Google Scholar 

Bilel S, Tirri M, Arfè R, Stopponi S, Soverchia L, Ciccocioppo R, Frisoni P, Strano-Rossi S, Miliano C, De-Giorgio F, Serpelloni G, Fantinati A, De Luca MA, Neri M, Marti M (2019) Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats. Front Neurosci 13:1163. https://doi.org/10.3389/fnins.2019.01163

Article  PubMed  PubMed Central  Google Scholar 

Bilel S, Tirri M, Arfè R, Ossato A, Trapella C, Serpelloni G, Neri M, Fattore L, Marti M (2020) Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice. Neurotoxicology 76:17–32. https://doi.org/10.1016/j.neuro.2019.10.002

Article  CAS  PubMed  Google Scholar 

Bilel S, Giorgetti A, Tirri M, Arfè R, Cristofori V, Marchetti B, Corli G, Caruso L, Zauli G, Giorgetti R, Marti M (2023) Sensorimotor alterations induced by novel fentanyl analogs in mice: possible impact on human driving performances. Curr Neuropharmacol 21(1):87–104. https://doi.org/10.2174/1570159X21666221116160032

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilhimer MH, Schult RF, Higgs KV, Wiegand TJ, Gorodetsky RM, Acquisto NM (2018) Acute intoxication following dimethyltryptamine ingestion. Case Reports in Emergency Medicine 3452691. https://doi.org/10.1155/2018/3452691

Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (2014) Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology 231(21):4135–4144. https://doi.org/10.1007/s00213-014-3557-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29(3):289–299. https://doi.org/10.1177/0269881114565144

Article  CAS  PubMed  Google Scholar 

Bouso JC, Andión Ó, Sarris JJ, Scheidegger M, Tófoli LF, Opaleye ES, Schubert V, Perkins D (2022) Adverse effects of ayahuasca: results from the Global Ayahuasca Survey. PLOS Global Public Health 2(11):e0000438. https://doi.org/10.1371/journal.pgph.0000438

Article  PubMed  PubMed Central  Google Scholar 

Buchborn T, Lyons T, Song C, Feilding A, Knöpfel T (2020) The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner. J Psychopharmacol 34(7):786–794. https://doi.org/10.1177/0269881120903465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canazza I, Ossato A, Trapella C, Fantinati A, De Luca MA, Margiani G, Vincenzi F, Rimondo C, Di Rosa F, Gregori A, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233(21–22):3685–3709. https://doi.org/10.1007/s00213-016-4402-y

Article  CAS  PubMed  Google Scholar 

Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology 235(2):521–534. https://doi.org/10.1007/s00213-017-4769-4

Article  CAS  PubMed  Google Scholar 

Chaouche-Teyara K, Fournier B, Safar M, Dabiré H (1994) Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat. Clin Exp Hypertens 16(6):779–798. https://doi.org/10.3109/10641969409078025

Article  CAS  PubMed  Google Scholar 

Corli G, Tirri M, Bilel S, Arfè R, Coccini T, Roda E, Marchetti B, Vincenzi F, Zauli G, Borea PA, Locatelli CA, Varani K, Marti M (2023) MAM-2201 acute administration impairs motor, sensorimotor, prepulse inhibition, and memory functions in mice: a comparison with its analogue AM-2201. Psychopharmacology 240(7):1435–1452. https://doi.org/10.1007/s00213-023-06378-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dabire H, Cherqui C, Fournier B, Schmitt H (1987) Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. Eur J Pharmacol 140(3):259–266. https://doi.org/10.1016/0014-2999(87)90282-2

Article  CAS  PubMed  Google Scholar 

Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR (2021) Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiat 78(5):481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285

Article  Google Scholar 

De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G (2021) Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. J Neurosci 41(5):891–900. https://doi.org/10.1523/JNEUROSCI.1659-20.2020

Article  PubMed  PubMed Central  Google Scholar 

De-Giorgio F, Bilel S, Tirri M, Arfè R, Trapella C, Camuto C, Foti F, Frisoni P, Neri M, Botrè F, Marti M (2020) Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users? Int J Legal Med 134(5):1695–1711. https://doi.org/10.1007/s00414-020-02302-3

Article  PubMed  Google Scholar 

Dipartimento Politiche Antidroga (2015) Relazione annuale al Parlamento 2015 sullo stato delle tossicodipendenze in Italia [Online] Available at: https://www.politicheantidroga.gov.it/it/attivita/relazioni-annuali-al-parlamento/relazione-annuale-al-parlamento-sul-fenomeno-delle-tossicodipendenze-in-italia-anno-2015-dati-2014/. Accessed 28 July 2023.

Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol 6(3):193–213. https://doi.org/10.1177/2045125316638008

Article  CAS  PubMed  PubMed Central  Google Scholar 

EMCDDA (2021) European drug report 2021: trends and developments. Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/18539

Article  Google Scholar 

EMCDDA (2022) European drug report 2022: trends and developments. Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/75644

Book  Google Scholar 

Erowid (2015a) 5-MeO-DIPT, effects [Online] Available at: https://erowid.org/chemicals/5meo_dipt/5meo_dipt_effects.shtml Accessed on 14/12/2023.

Erowid (2015b) 5-MeO-MiPT, effects [Online] Available at: https://erowid.org/chemicals/5meo_mipt/5meo_mipt_effects.shtml. Accessed 28 July 2023.

Erowid (2015c) DMT, effects [Online] Available at: https://erowid.org/chemicals/dmt/dmt_effects.shtml Accessed on 14/12/2023.

ESPAD (2020) ESPAD Report 2019: results from the european school survey project on alcohol and other drugs, EMCDDA Joint Publications, Publications Office of the European Union, Luxembourg

Fan J, de Lannoy IA (2014) Pharmacokinetics. Biochem Pharmacol 87(1):93–120. https://doi.org/10.1016/j.bcp.2013.09.007

Article  CAS  PubMed  Google Scholar 

Fantegrossi WE, Murnane KS, Reissig CJ (2008) The behavioral pharmacology of hallucinogens. Biochem Pharmacol 75(1):17–33. https://doi.org/10.1016/j.bcp.2007.07.018

Article  CAS  PubMed  Google Scholar 

Fattore L, Marti M, Mostallino R, Castelli MP (2020) Sex and gender differences in the effects of novel psychoactive substances. Brain Sci 10(9):606. https://doi.org/10.3390/brainsci10090606

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frishman WH, Grewall P (2000) Serotonin and the heart. Ann Med 32(3):195–209. https://doi.org/10.3109/07853890008998827

Article  CAS  PubMed  Google Scholar 

Giannini EG, Testa R, Savarino V (2005) Liver enzyme alteration: a guide for clinicians. Can Med Assoc J 172(3):367–379. https://doi.org/10.1503/cmaj.1040752

Article  Google Scholar 

Grafinger KE, Hädener M, König S, Weinmann W (2018) Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples. Drug Test Anal 10(3):562–574. https://doi.org/10.1002/dta.2245

Article  CAS  PubMed